Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Athersys Inc
(NQ:
ATHX
)
2.220
USD
+0.070 (+3.26%)
Streaming Delayed Price
Updated: 7:11 AM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Athersys Inc
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Market Trends Toward New Normal in Crown, Athersys, CSX, Magellan Health, Spectrum Brands, and MGIC Investment — Emerging Consolidated Expectations, Analyst Ratings
October 29, 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Crown Holdings, Inc....
From
GlobeNewswire News Releases
Athersys to Host Third Quarter Financial Results Call
October 09, 2018
Athersys, Inc. (NASDAQ: ATHX) will release its third quarter 2018 financial results at approximately 4:00 p.m. Eastern Time on Tuesday, November 6th, 2018, and will host a conference call shortly...
From
GlobeNewswire News Releases
Increasing Number of Cancer Cases to Fuel the Global Cancer Immunotherapy Market Growth
October 05, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
Add Up The Parts: IWN Could Be Worth $147
September 27, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Athersys to Present at 2018 Cell & Gene Meeting on the Mesa
September 23, 2018
Athersys, Inc. (NASDAQ: ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present at the annual Cell & Gene Meeting on the Mesa to be held October 3rd-5th in La Jolla, California.
From
GlobeNewswire News Releases
Commit To Purchase Athersys At $2, Earn 30.7% Annualized Using Options
August 23, 2018
Investors considering a purchase of Athersys Inc (ATHX) shares, but cautious about paying the going market price of $2.02/share, might benefit from considering selling puts among the alternative...
Tags
Stocks
From
Market News Video
Recent Analysis Shows Williams Partners, GameStop, Opko Health, Athersys, CSX, and Kratos Defense & Security Solutions Market Influences — Renewed Outlook, Key Drivers of Growth
August 14, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Williams Partners L.P....
From
GlobeNewswire News Releases
Analysts Anticipate 10% Gains Ahead For The Holdings of SPTM
August 13, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Athersys Reports Second Quarter 2018 Results
August 07, 2018
Management to host conference call at 4:30pm EDT today
From
GlobeNewswire News Releases
The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel
August 07, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ...
Tags
FLXN
FBIO
HTGM
From
Benzinga
The Growth of Stem Cell Applications are Contributing to the Cell Therapy Processing Market
August 06, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
Athersys Makes Important Leadership Hire to Carry Out Its Manufacturing Strategy
August 02, 2018
Company Appoints Greg Liposky, MBA as Senior Vice President of Commercial Manufacturing
From
GlobeNewswire News Releases
Athersys Announces Enrollment of First Patient in Masters-2 Phase 3 Study of Multistem® Treatment for Ischemic Stroke
July 30, 2018
Athersys, Inc. (NASDAQ: ATHX) announced today that the first patient has been enrolled its Phase 3 study entitled, MultiStem Administration for Stroke Treatment and Enhanced Recovery Study-2...
From
GlobeNewswire News Releases
Biotechnology Companies Involved in Regenerative Medicine
July 12, 2018
From
ACCESSWIRE
Stem Cell Companies Innovating for the Future
July 12, 2018
From
PR Newswire
Rise of Chronic Diseases Leads to Growing Investment in Stem Cell Research
July 11, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
Athersys to Host Second Quarter Financial Results Call
July 10, 2018
Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7th, 2018, and will host a conference call shortly...
From
GlobeNewswire News Releases
Analysts Expect 12% Upside For The Holdings of IWO
June 26, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
48 Biggest Movers From Yesterday
June 19, 2018
Gainers Astrotech Corporation (NASDAQ: ASTC) shares surged 217.44 percent to close at $6.1901 on Tuesday after the ...
Tags
ZKIN
COCP
PAGS
From
Benzinga
23 Stocks Moving In Thursday's Pre-Market Session
June 14, 2018
Gainers Teligent, Inc. (NASDAQ: TLGT) shares rose 21.4 percent to $3.97 in pre-market trading following the FDA approval of ...
Tags
#PreMarket Gainers
TLRD
APTO
From
Benzinga
44 Biggest Movers From Yesterday
June 11, 2018
Gainers Nano Dimension Ltd. (NASDAQ: NNDM) shares climbed 101.41 percent to close at $2.68 on Monday. The additive ...
Tags
NTLA
GEVO
HMI
From
Benzinga
32 Stocks Moving In Monday's Mid-Day Session
June 11, 2018
Gainers Nano Dimension Ltd. (NASDAQ: NNDM) shares jumped 132.1 percent to $3.11 in pre-market trading. The additive ...
Tags
SYK
PFIE
GNW
From
Benzinga
Monday Sector Laggards: Biotechnology, General Contractors & Builders
June 11, 2018
In trading on Monday, biotechnology shares were relative laggards, down on the day by about 0.4%. Helping drag down the group were shares of TapImmune, down about 8.4% and shares of Athersys off about...
Tags
Stocks
From
Market News Video
Innovative Biotech Companies Pushing the Envelope
June 11, 2018
From
PR Newswire
36 Stocks Moving In Thursday's Mid-Day Session
June 07, 2018
Gainers Top Ships Inc. (NASDAQ: TOPS) shares climbed 78.6 percent to $1.3751 after the company reported a time charter with ...
Tags
VBLT
Market News
AXON
From
Benzinga
Benzinga Pro's 5 Stocks To Watch Today
June 07, 2018
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ...
Tags
REVG
News
Pre/Market Outlook
From
Benzinga
27 Stocks Moving In Thursday's Pre-Market Session
June 07, 2018
Gainers AV Homes, Inc. (NASDAQ: AVHI) shares rose 24.2 percent to $20.50 in pre-market trading after Taylor Morrison Home ...
Tags
AVHI
ABM
ICPT
From
Benzinga
Athersys Announces Expansion of Collaboration With Healios
June 06, 2018
Athersys, Inc. (NASDAQ:ATHX) announced today that it has entered into an agreement with HEALIOS K.K. (“Healios”) to expand their collaboration into additional therapeutic areas. Under the terms of the...
From
GlobeNewswire News Releases
Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate
June 06, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ...
Tags
DCPH
INGN
Biotech
From
Benzinga
Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index
June 05, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ...
Tags
SCPH
VSTM
ABMD
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.